Hip

DePuy Synthes Mitek Sports Med Unveils a New Hybrid Anchor Technology for Arthroscopic Repair of Shoulder and Hip Instability

Ortho Development® Corporation has received FDA clearance for its Ovation Tribute™ Hip Stem. The Ovation Tribute is a femoral hip prosthesis that is intended for cementless use in total hip replacement and hemiarthroplasty procedures.

After all the hoo haa of the last few years pertaining to the damaging outcome of some metal-on-metal hip implants, US patient advocacy group The Drugs Watchdog has now issued a press release strongly suggesting DePuy Pinnacle all metal hip implantees contact it to discuss their options, the most likely suggestion being to demand an MRI.

Smith & Nephew says its newly launched DYONICS PLAN system allows surgeons to visualize, assess and generate a comprehensive surgical report for each patient’s unique Femoroacetabular impingement surgery before that patient ever enters the operating room.

Stryker Corporation tells us it has completed its previously announced all-cash acquisition of Pivot Medical Inc., a move the Kalamazoo device company will hope enhances its position in the orthopaedic sports medicine and arthroscopy specialties.

Stryker Corporation is to acquire Pivot Medical, Inc., developer of  innovative products for hip arthroscopy in a deal the details … continue reading “Stryker to Acquire Hip Arthroscopy Company, Pivot Medical”

Biomet, Inc. has reached a settlement amounting to $56 million in Multi-District Litigation (MDL) 2391 relating to its M2A Magnum Hip Implant Products.

Hip fracture fixation company, X-Bolt Orthopaedics, based in Dublin, has completed an equity investment round of €1.8 million which it says will advance FDA clearance for its X-Bolt product in the US and fast track commercialisation of the product to the global export market.

Johnson & Johnson is considering a settlement with injured hip implant patients that could total more than $3 billion. Sources close to the matter have told Bloomberg that the company is weighing their options in settling thousands of cases involving DePuy hip implants that have been linked to early failure rates and a host of serious complications.

It seems San Francisco’s Invuity, Inc., has hit on a rich vein of unmet need as its clever illuminated retractor systems featured heavily in the last two weeks at both an anterior hip arthroplasty course and an innovation technology showcase hosted by one of the big healthcare supply chain companies.

MIS device company Surgical Innovations Group plc, has for a while been developing its own hip arthroscopy access system. Now it has got as far as pilot testing in a cadaveric model and declared the test a success.

Metal-on-metal hip problems are associated with J&J’s DePuy division with its infamous and ongoing ASR tribulations. Stryker isn’t without its … continue reading “Stryker ABG II Lawsuit Claim For $100M”

Two main court cases attracted our interest this week. While the situations contrast, the common thread of patient suffering runs through both cases.

Consumer protection activist organisation, Consumers Union has urged the U.S. FDA today to adopt a proposed rule requiring metal hip implants to be reviewed through the agency’s premarket approval (PMA) process to prove that the devices are safe and effective.

Now we weren’t expecting that. With DePuy ASR trials there was a thought that it would be a matter of how much rather than whether there was an award or not. Seemingly not true as an Illinois jury finds in favour of the company and offers no settlement.

It’s all very well getting aerated about medical device failures, but it’s equally very easy to throw out the baby with the bathwater. We consider whether draconian regs would do what they’re intended to do, and whether they’d stifle innovation in the interest of…well, nobody.